Annual SG&A
$2.16 M
+$1.93 M+853.45%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual selling, general & administrative expenses is currently $2.16 million, with the most recent change of +$1.93 million (+853.45%) on 01 December 2023. During the last 3 years, it has risen by +$2.11 million (+4962.68%). LIPO annual SG&A is now at all-time high.LIPO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$493.10 K
+$66.00 K+15.45%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly selling, general & administrative expenses is currently $493.10 thousand, with the most recent change of +$66.00 thousand (+15.45%) on 01 September 2024. Over the past year, it has increased by +$96.90 thousand (+24.46%). LIPO quarterly SG&A is now -21.42% below its all-time high of $627.50 thousand, reached on 01 September 2023.LIPO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$48.19 M
-$4.26 M-9.71%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock TTM selling, general & administrative expenses is currently -$48.19 million, with the most recent change of -$4.26 million (-9.71%) on 01 September 2024. Over the past year, it has dropped by -$50.35 million (-2334.51%). LIPO TTM SG&A is now -1450.97% below its all-time high of $2.17 million, reached on 01 March 2024.LIPO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +24.5% | -2334.5% |
| 3 y3 years | +4962.7% | +432.5% | -6808.2% |
| 5 y5 years | - | - | - |
LIPO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +4962.7% | -21.4% | +1431.4% | -1451.0% | at low |
| 5 y | 5 years | at high | +4962.7% | -21.4% | +1431.4% | -1451.0% | at low |
| alltime | all time | at high | +4962.7% | -21.4% | +1431.4% | -1451.0% | at low |
Lipella Pharmaceuticals Common Stock Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $493.10 K(+15.5%) | $1.84 M(-6.8%) |
| June 2024 | - | $427.10 K(-18.0%) | $1.97 M(-9.1%) |
| Mar 2024 | - | $520.90 K(+31.5%) | $2.17 M(+0.6%) |
| Dec 2023 | $2.16 M(+853.4%) | $396.20 K(-36.9%) | $2.16 M(+20.3%) |
| Sept 2023 | - | $627.50 K(+0.5%) | $1.79 M(+46.1%) |
| June 2023 | - | $624.20 K(+22.7%) | $1.23 M(+91.3%) |
| Mar 2023 | - | $508.80 K(+1480.1%) | $641.20 K(+183.3%) |
| Dec 2022 | $226.20 K | $32.20 K(-47.8%) | $226.30 K(-21.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $61.70 K(+60.3%) | $286.70 K(+5.9%) |
| June 2022 | - | $38.50 K(-59.0%) | $270.80 K(-27.4%) |
| Mar 2022 | - | $93.90 K(+1.4%) | $373.20 K(-48.1%) |
| Dec 2021 | $718.40 K(+1586.4%) | - | - |
| Dec 2021 | - | $92.60 K(+102.2%) | $718.40 K(+14.8%) |
| Sept 2021 | - | $45.80 K(-67.5%) | $625.80 K(+7.9%) |
| June 2021 | - | $140.90 K(-67.9%) | $580.00 K(+32.1%) |
| Mar 2021 | - | $439.10 K | $439.10 K |
| Dec 2020 | $42.60 K | - | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly SG&A year-on-year change?
- What is Lipella Pharmaceuticals Common Stock TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock TTM SG&A year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual selling, general & administrative expenses?
The current annual SG&A of LIPO is $2.16 M
What is the all time high annual SG&A for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual selling, general & administrative expenses is $2.16 M
What is Lipella Pharmaceuticals Common Stock quarterly selling, general & administrative expenses?
The current quarterly SG&A of LIPO is $493.10 K
What is the all time high quarterly SG&A for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly selling, general & administrative expenses is $627.50 K
What is Lipella Pharmaceuticals Common Stock quarterly SG&A year-on-year change?
Over the past year, LIPO quarterly selling, general & administrative expenses has changed by +$96.90 K (+24.46%)
What is Lipella Pharmaceuticals Common Stock TTM selling, general & administrative expenses?
The current TTM SG&A of LIPO is -$48.19 M
What is the all time high TTM SG&A for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high TTM selling, general & administrative expenses is $2.17 M
What is Lipella Pharmaceuticals Common Stock TTM SG&A year-on-year change?
Over the past year, LIPO TTM selling, general & administrative expenses has changed by -$50.35 M (-2334.51%)